We are live on ! Find out more
SRTA

Strata Critical Medical Inc

114 hedge funds and large institutions have $107M invested in Strata Critical Medical Inc in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

38% more call options, than puts

Call options by funds: $568K | Put options by funds: $411K

12% more funds holding

Funds holding: 102114 (+12)

1.08% more ownership

Funds ownership: 48.61%49.69% (+1.1%)

17% less capital invested

Capital invested by funds: $128M → $107M (-$21.3M)

27% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 41

Holders
114
Holders Change
+12
Holders Change %
+11.76%
% of All Funds
1.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
30
Reduced
41
Closed
10
Calls
$568K
Puts
$411K
Net Calls
+$157K
Net Calls Change
-$233K
Name Holding Trade Value Shares
Change
Change in
Stake
IP
26
Intellectus Partners
California
$615K +$4.63K +1,500 +0.7%
Jane Street
27
Jane Street
New York
$534K +$248K +80,542 +75%
Man Group
28
Man Group
United Kingdom
$509K +$551K +178,694 New
Goldman Sachs
29
Goldman Sachs
New York
$481K -$75.7K -24,546 -13%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$461K -$36.7K -11,883 -7%
Charles Schwab
31
Charles Schwab
California
$450K -$32.7K -10,595 -6%
Barclays
32
Barclays
United Kingdom
$430K -$125K -40,449 -21%
AGC
33
Aspen Grove Capital
Colorado
$356K
Invesco
34
Invesco
Georgia
$322K +$277K +89,778 +388%
SPA
35
Sherbrooke Park Advisers
New York
$302K +$289K +93,512 +754%
UBS Group
36
UBS Group
Switzerland
$290K -$21.8K -7,059 -6%
AIM
37
Allen Investment Management
New York
$285K
GC
38
Guggenheim Capital
Illinois
$273K -$11.2K -3,630 -4%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$254K -$20.9K -6,761 -7%
Bank of America
40
Bank of America
North Carolina
$221K -$333K -108,024 -58%
American Century Companies
41
American Century Companies
Missouri
$196K +$55K +17,838 +35%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$195K -$183K -59,300 -46%
OAM
43
Oxford Asset Management
United Kingdom
$183K +$198K +64,127 New
VF
44
Virtu Financial
New York
$171K +$185K +60,092 New
HSBC Holdings
45
HSBC Holdings
United Kingdom
$163K +$21.2K +6,860 +14%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$159K -$314K -101,826 -65%
Stifel Financial
47
Stifel Financial
Missouri
$152K +$40.5K +13,136 +33%
XT
48
XTX Topco
Cayman Islands
$143K +$46.8K +15,157 +43%
Millennium Management
49
Millennium Management
New York
$117K -$35.9K -11,638 -22%
Cerity Partners
50
Cerity Partners
New York
$107K -$1.13M -365,002 -91%

SRTA Hedge Fund Activity: Q1 2024 in Review

114 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q1 2024, worth a combined $107M — down 17% from $128M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SRTA positions and 10 closed out — a net gain of 12 holders — while 30 added to existing stakes and 41 trimmed.

The largest buyer was AWM Investment Company, adding an estimated $2.31M. The largest seller was Morgan Stanley, cutting an estimated $4.76M.

  • 114 institutional investors held Strata Critical Medical Inc (SRTA) as of Q1 2024, up from 102 in Q4 2023.
  • Funds reported $107M of Strata Critical Medical Inc stock for Q1 2024, down 17% quarter-over-quarter.
  • 22 funds opened new Strata Critical Medical Inc positions in Q1 2024 and 10 closed out, a net change of +12 holders.
  • The largest Strata Critical Medical Inc buyer in Q1 2024 was AWM Investment Company, an estimated $2.31M added.
  • The largest Strata Critical Medical Inc seller in Q1 2024 was Morgan Stanley, an estimated $4.76M sold.

Based on aggregated 13F filings for Q1 2024.